N6-methyladenosine (m6A) is the most prevalent internal mRNA modification. m6A can be
installed by the methyltransferase complex and removed by demethylases, which are …

Antibiotic resistance is a significant public health issue, causing illnesses that were once
easily treatable with antibiotics to develop into dangerous infections, leading to substantial …

Lenvatinib is emerging as the first-line therapeutic option for advanced hepatocellular
carcinoma (HCC), but drug resistance remains a major hurdle for its long-term therapy …

Background Cervical cancer (CC) is one of the most common gynecological tumors that
threatens women's health and lives. Aberrant expression of PIWI-interacting RNA (piRNA) is …

Radiotherapy is a valid treatment for nasopharyngeal carcinoma (NPC), and radioresistance
is the main cause of local NPC treatment failure. However, the underlying mechanisms and …

Inflammatory bowel disease (IBD) results from a complex interplay between genetic
predisposition, environmental factors, and gut microbes. The role of N6-methyladenosine …

Cells have evolved a robust and highly regulated DNA damage response to preserve their
genomic integrity. Although increasing evidence highlights the relevance of RNA regulation …

Background Having emerged as the most abundant posttranscriptional internal mRNA
modification in eukaryotes, N6‐methyladenosine (m6A) has attracted tremendous scientific …

RNA N6‐methyladenosine modification is the most prevalent internal modification of
eukaryotic RNAs and has emerged as a novel field of RNA epigenetics, garnering increased …

Hepatitis B virus (HBV) contains a partially double-stranded DNA genome. During infection,
its replication is mediated by reverse transcription (RT) of an RNA intermediate termed …